Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Specialization of small non-conjugative plasmids in Escherichia coli according to their family types.

Branger C, Ledda A, Billard-Pomares T, Doublet B, Barbe V, Roche D, Médigue C, Arlet G, Denamur E.

Microb Genom. 2019 Aug 7. doi: 10.1099/mgen.0.000281. [Epub ahead of print]

2.

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials.

Larocca A, Mina R, Offidani M, Liberati AM, Ledda A, Patriarca F, Evangelista A, Spada S, Benevolo G, Oddolo D, Innao V, Cangialosi C, Bernardini A, Musto P, Amico V, Fraticelli V, Paris L, Giuliani N, Falcone AP, Zambello R, De Paoli L, Romano A, Palumbo A, Montefusco V, Hajek R, Boccadoro M, Bringhen S.

Haematologica. 2019 Jun 27. pii: haematol.2019.220657. doi: 10.3324/haematol.2019.220657. [Epub ahead of print]

3.

PRDM9 Diversity at Fine Geographical Scale Reveals Contrasting Evolutionary Patterns and Functional Constraints in Natural Populations of House Mice.

Vara C, Capilla L, Ferretti L, Ledda A, Sánchez-Guillén RA, Gabriel SI, Albert-Lizandra G, Florit-Sabater B, Bello-Rodríguez J, Ventura J, Searle JB, Mathias ML, Ruiz-Herrera A.

Mol Biol Evol. 2019 Aug 1;36(8):1686-1700. doi: 10.1093/molbev/msz091.

4.

Pycnogenol®: supplementary management of symptomatic osteoarthritis with a patch. An observational registry study.

Feragalli B, Dugall M, Luzzi R, Ledda A, Hosoi M, Belcaro G, Cesarone MR.

Minerva Endocrinol. 2019 Mar;44(1):97-101. doi: 10.23736/S0391-1977.18.02820-1.

PMID:
30561176
5.

Temporary kidney dysfunction (TKD): supplementation with Meriva® in initial, transient kidney micro-macro albuminuria.

Ledda A, Belcaro G, Feragalli B, Hosoi M, Cacchio M, Luzzi R, Dugall M, Cotellese R.

Panminerva Med. 2018 Nov 27. doi: 10.23736/S0031-0808.18.03575-9. [Epub ahead of print]

6.

Efficacy of Pycnogenol® supplementation in remission phases of Sjögren syndrome.

Luzzi R, Belcaro G, Hu S, Feragalli B, Hosoi M, Dugall M, Ledda A.

Minerva Cardioangiol. 2018 Oct;66(5):543-546. doi: 10.23736/S0026-4725.18.04638-8.

PMID:
30328688
7.

Creative Argumentation: When and Why People Commit the Metaphoric Fallacy.

Ervas F, Ledda A, Ojha A, Pierro GA, Indurkhya B.

Front Psychol. 2018 Sep 25;9:1815. doi: 10.3389/fpsyg.2018.01815. eCollection 2018.

8.

Mononucleosis-related fatigue: supplementary management with Robuvit®.

Hu S, Belcaro G, Ledda A, Corsi M, Cotellese R, Feragalli B, Hosoi M, Dugall M, Torino-Rodriguez P, Cesarone MR.

Minerva Pediatr. 2018 Oct;70(5):425-429. doi: 10.23736/S0026-4946.18.05213-1.

PMID:
30302988
9.

Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation.

Proietti R, Gonzini L, Pizzimenti G, Ledda A, Sanna P, AlTurki A, Russo V, Lencioni M; ATA-AF Investigators.

Clin Cardiol. 2018 Dec;41(12):1570-1577. doi: 10.1002/clc.23065. Epub 2018 Dec 4.

10.

Extended-spectrum β-lactamase-encoding genes are spreading on a wide range of Escherichia coli plasmids existing prior to the use of third-generation cephalosporins.

Branger C, Ledda A, Billard-Pomares T, Doublet B, Fouteau S, Barbe V, Roche D, Cruveiller S, Médigue C, Castellanos M, Decré D, Drieux-Rouze L, Clermont O, Glodt J, Tenaillon O, Cloeckaert A, Arlet G, Denamur E.

Microb Genom. 2018 Sep;4(9). doi: 10.1099/mgen.0.000203. Epub 2018 Aug 6.

11.

Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®).

Hu S, Belcaro G, Dugall M, Peterzan P, Hosoi M, Ledda A, Riva A, Giacomelli L, Togni S, Eggenhoffner R, Cotellese R.

Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):5042-5046. doi: 10.26355/eurrev_201808_15647.

12.

Behçet syndrome: effects of Pycnogenol® supplementation during regression phases.

Hu S, Belcaro G, Ledda A, Corsi M, Cotellese R, Feragalli B, Hosoi M, Dugall M, Torino-Rodriguez P, Cesarone MR.

Minerva Cardioangiol. 2018 Aug;66(4):386-390. doi: 10.23736/S0026-4725.18.04637-6.

PMID:
29975020
13.

Benign prostatic hypertrophy: Pycnogenol® supplementation improves prostate symptoms and residual bladder volume.

Ledda A, Belcaro G, Feragalli B, Cornelli U, Dugall M, Corsi M, Cesarone MR.

Minerva Med. 2018 Aug;109(4):280-284. doi: 10.23736/S0026-4806.18.05572-6.

PMID:
29947491
14.

Prevention of recurrent venous thrombosis and post-thrombotic syndrome.

Belcaro G, Dugall M, Hu S, Feragalli B, Cotellese R, Ledda A, Corsi M, Ricci A, Ippolito E, Errichi BM, Cornelli U, Cesarone MR, Hosoi M.

Minerva Cardioangiol. 2018 Jun;66(3):238-245. doi: 10.23736/S0026-4725.18.04618-2.

PMID:
29795059
15.

Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria.

Ledda A, Belcaro G, Feragalli B, Hosoi M, Cacchio M, Luzzi R, Dugall M, Cotellese R, Cesarone MR.

Panminerva Med. 2018 Jun;60(2):60-64. doi: 10.23736/S0031-0808.18.03420-1.

16.

Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure.

Mancuso L, Vitrano A, Mancuso A, Sacco M, Ledda A, Maggio A.

Hemoglobin. 2018 Jan;42(1):68-71. doi: 10.1080/03630269.2018.1451341.

PMID:
29633668
17.

Centella asiatica (Centellicum®) facilitates the regular healing of surgical scars in subjects at high risk of keloids.

Cotellese R, Hu S, Belcaro G, Ledda A, Feragalli B, Dugall M, Hosoi M, Ippolito E.

Minerva Chir. 2018 Apr;73(2):151-156. doi: 10.23736/S0026-4733.18.07666-6.

PMID:
29623705
18.

Testicular development in male lambs prenatally exposed to a high-starch diet.

Mossa F, Bebbere D, Ledda A, Burrai GP, Chebli I, Antuofermo E, Ledda S, Cannas A, Fancello F, Atzori AS.

Mol Reprod Dev. 2018 May;85(5):406-416. doi: 10.1002/mrd.22974. Epub 2018 Mar 30.

PMID:
29542837
19.

Phytoproflex®: supplementary management of osteoarthrosis: a supplement registry.

Belcaro G, Dugall M, Luzzi R, Hosoi M, Ledda A, Feragalli B, Hu S, Ganguly A, Eggenhoffner R, Corti A, Giacomelli L.

Minerva Med. 2018 Apr;109(2):88-94. doi: 10.23736/S0026-4806.17.05460-X.

20.

A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study.

Ledda A, Belcaro G, Dugall M, Luzzi R, Hosoi M, Feragalli B, Cotellese R, Cosentino V, Cosentino M, Eggenhoffner R, Pellizzato M, Fratter A, Giacomelli L.

Eur Rev Med Pharmacol Sci. 2017 Sep;21(18):4196-4202.

21.

Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings.

Belcaro G, Dugall M, Luzzi R, Corsi M, Ledda A, Ricci A, Pellegrini L, Cesarone MR, Hosoi M, Errichi BM, Cornelli U, Cotellese R, Agus G, Feragalli B.

Int J Angiol. 2017 Sep;26(3):170-178. doi: 10.1055/s-0036-1597756. Epub 2016 Dec 28.

22.

Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures.

Caporale R, Geraci G, Gulizia MM, Borzi M, Colivicchi F, Menozzi A, Musumeci G, Scherillo M, Ledda A, Tarantini G, Gerometta P, Casolo G, Formigli D, Romeo F, Di Bartolomeo R.

Eur Heart J Suppl. 2017 May;19(Suppl D):D151-D162. doi: 10.1093/eurheartj/sux010. Epub 2017 May 2.

23.

Decomposing the Site Frequency Spectrum: The Impact of Tree Topology on Neutrality Tests.

Ferretti L, Ledda A, Wiehe T, Achaz G, Ramos-Onsins SE.

Genetics. 2017 Sep;207(1):229-240. doi: 10.1534/genetics.116.188763. Epub 2017 Jul 5.

24.

Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency.

Sanna M, Caocci G, Orrù F, Ledda A, Vacca A, Piras E, Fozza C, Deias P, Tidore G, Dore F, La Nasa G.

J Clin Pharm Ther. 2017 Dec;42(6):733-737. doi: 10.1111/jcpt.12571. Epub 2017 Jun 8.

PMID:
28597476
25.

Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia.

Sanna M, Caocci G, Ledda A, Orrù F, Fozza C, Deias P, Tidore G, Dore F, La Nasa G.

Leuk Lymphoma. 2017 Nov;58(11):2558-2564. doi: 10.1080/10428194.2017.1312666. Epub 2017 Apr 12.

PMID:
28402154
26.

Highly standardized cranberry extract supplementation (Anthocran®) as prophylaxis in young healthy subjects with recurrent urinary tract infections.

Ledda A, Belcaro G, Dugall M, Riva A, Togni S, Eggenhoffner R, Giacomelli L.

Eur Rev Med Pharmacol Sci. 2017 Jan;21(2):389-393.

27.

Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.

Luzzi R, Belcaro G, Hosoi M, Feragalli B, Cornelli U, Dugall M, Ledda A.

Minerva Ginecol. 2017 Feb;69(1):29-34. doi: 10.23736/S0026-4784.16.03913-7.

PMID:
28116886
28.

Re-emergence of methicillin susceptibility in a resistant lineage of Staphylococcus aureus.

Ledda A, Price JR, Cole K, Llewelyn MJ, Kearns AM, Crook DW, Paul J, Didelot X.

J Antimicrob Chemother. 2017 May 1;72(5):1285-1288. doi: 10.1093/jac/dkw570.

29.
30.

A novel lecithin based delivery form of Boswellic acids (Casperome®) for the management of osteo-muscular pain: a registry study in young rugby players.

Franceschi F, Togni S, Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Eggenhoffner R, Giacomelli L.

Eur Rev Med Pharmacol Sci. 2016 Oct;20(19):4156-4161.

31.

Data related to inflammation and cholesterol deposition triggered by macrophages exposition to modified LDL.

Toledo J, Esteve M, Grasa M, Ledda A, Garda H, Gulfo J, Ludovico ID, Ramella N, Gonzalez M.

Data Brief. 2016 May 27;8:251-7. doi: 10.1016/j.dib.2016.05.046. eCollection 2016 Sep.

32.

Altered lipid partitioning and glucocorticoid availability in CBG-deficient male mice with diet-induced obesity.

Gulfo J, Ledda A, Serra E, Cabot C, Esteve M, Grasa M.

Obesity (Silver Spring). 2016 Aug;24(8):1677-86. doi: 10.1002/oby.21543. Epub 2016 Jun 21.

33.

[ANMCO/SIC/SICI-GISE/SICCH Consensus document: Clinical approach to pharmacological pretreatment for patients undergoing myocardial revascularization].

Caporale R, Geraci G, Gulizia MM, Borzi M, Colivicchi F, Menozzi A, Musumeci G, Scherillo M, Ledda A, Tarantini G, Gerometta P, Casolo G, Formigli D, Romeo F, Di Bartolomeo R; ANMCO/SIC/SICI-GISE/SICCH:.

G Ital Cardiol (Rome). 2016 Jun;17(6):462-90. doi: 10.1714/2262.24352. Italian.

PMID:
27311089
34.

Decreased OxLDL uptake and cholesterol efflux in THP1 cells elicited by cortisol and by cortisone through 11β-hydroxysteroid dehydrogenase type 1.

Ledda A, González M, Gulfo J, Díaz Ludovico I, Ramella N, Toledo J, Garda H, Grasa M, Esteve M.

Atherosclerosis. 2016 Jul;250:84-94. doi: 10.1016/j.atherosclerosis.2016.04.020. Epub 2016 Apr 28.

PMID:
27187933
35.

New Roles for Corticosteroid Binding Globulin and Opposite Expression Profiles in Lung and Liver.

Gulfo J, Ledda A, Gea-Sorlí S, Bonjoch L, Closa D, Grasa M, Esteve M.

PLoS One. 2016 Jan 7;11(1):e0146497. doi: 10.1371/journal.pone.0146497. eCollection 2016.

36.

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma.

Magarotto V, Bringhen S, Offidani M, Benevolo G, Patriarca F, Mina R, Falcone AP, De Paoli L, Pietrantuono G, Gentili S, Musolino C, Giuliani N, Bernardini A, Conticello C, Pulini S, Ciccone G, Maisnar V, Ruggeri M, Zambello R, Guglielmelli T, Ledda A, Liberati AM, Montefusco V, Hajek R, Boccadoro M, Palumbo A.

Blood. 2016 Mar 3;127(9):1102-8. doi: 10.1182/blood-2015-08-662627. Epub 2016 Jan 4. Erratum in: Blood. 2018 Mar 29;131(13):1495.

37.

Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.

Belcaro G, Dugall M, Ippolito E, Hosoi M, Cornelli U, Ledda A, Scoccianti M, Cesarone MR, Pellegrini L, Luzzi R, Corsi M, Feragalli B.

Minerva Cardioangiol. 2017 Feb;65(1):24-31. doi: 10.23736/S0026-4725.16.04008-1. Epub 2015 Oct 27.

PMID:
26505327
38.

Miraqule-C and mild heart failure: an 8-week registry.

Belcaro G, Dugall M, Hu S, Corsi M, Hosoi M, Luzzi R, Ippolito E, Feragalli B, Ledda A.

Minerva Gastroenterol Dietol. 2015 Oct 22. [Epub ahead of print]

PMID:
26492589
39.

Supplementary management of benign prostatic hypertrophy with Prostaquil. An 8-week registry.

Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Hosoi M, Errichi BM, Francis S, Cornelli U.

Minerva Gastroenterol Dietol. 2015 Oct 22. [Epub ahead of print]

PMID:
26492588
40.

Management of osteoarthritis (OA) with the pharma-standard supplement FlexiQule (Boswellia): a 12-week registry.

Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Hu S, Ippolito E.

Minerva Gastroenterol Dietol. 2015 Oct 22. [Epub ahead of print]

PMID:
26492586
41.

Liverubin (standardized silymarin) in the supplementary management of functional, temporary hepatic damage. A pilot, registry, study.

Belcaro G, Hu S, Gizzi G, Corsi M, Dugall M, Hu S, Pellegrini L, Ledda A, Cornelli U, Cesarone MR, Hosoi M, Luzzi R.

Minerva Med. 2014 Dec;105(6 Suppl 2):17-25.

PMID:
26076377
42.

FlexiQule (Boswellia extract) in the supplementary management of osteoarthritis: a supplement registry.

Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Cesarone MR, Hosoi M, Errichi M, Francis S, Cornelli U.

Minerva Med. 2014 Dec;105(6 Suppl 2):9-16.

PMID:
26076376
43.

Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.

Rodriguez P, Belcaro G, Dugall M, Hu S, Luzzi R, Ledda A, Ippolito E, Corsi M, Ricci A, Feragalli B, Cornelli U, Gizzi C, Hosoi M.

Panminerva Med. 2015 Sep;57(3):121-5.

PMID:
25971329
44.

Is the use of risk scores an indicator of guideline adherence for patients with acute coronary syndromes? Insights from the EYESHOT Registry.

De Luca L, Leonardi S, Tubaro M, Gonzini L, Lucci D, Trimarco B, Misuraca G, Ledda A, Gulizia MM, De Servi S; EYESHOT Investigators.

Int J Cardiol. 2015;187:80-3. doi: 10.1016/j.ijcard.2015.03.343. Epub 2015 Mar 24. No abstract available.

PMID:
25828318
45.

French Oak Wood (Quercus robur) Extract (Robuvit) in Primary Lymphedema: A Supplement, Pilot, Registry Evaluation.

Belcaro G, Dugall M, Hu S, Ledda A, Ippolito E.

Int J Angiol. 2015 Mar;24(1):47-54. doi: 10.1055/s-0034-1395982.

46.

Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study.

Ledda A, Bottari A, Luzzi R, Belcaro G, Hu S, Dugall M, Hosoi M, Ippolito E, Corsi M, Gizzi G, Morazzoni P, Riva A, Giacomelli L, Togni S.

Eur Rev Med Pharmacol Sci. 2015 Jan;19(1):77-80.

47.

Meriva®+Glucosamine versus Condroitin+Glucosamine in patients with knee osteoarthritis: an observational study.

Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Cesarone MR, Hosoi M, Errichi M.

Eur Rev Med Pharmacol Sci. 2014;18(24):3959-63.

48.

Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.

Belcaro G, Ippolito E, Dugall M, Hosoi M, Cornelli U, Ledda A, Scoccianti M, Steigerwalt RD, Cesarone MR, Pellegrini L, Luzzi R, Corsi M.

Int Angiol. 2015 Apr;34(2):150-7. Epub 2014 Dec 18.

PMID:
25519846
49.

Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study.

Belcaro G, Cornelli U, Luzzi R, Ledda A, Cacchio M, Saggino A, Cesarone MR, Dugall M, Feragalli B, Hu S, Pellegrini L, Ippolito E.

J Neurosurg Sci. 2015 Jun;59(2):105-17. Epub 2014 Nov 14.

PMID:
25394351
50.

Toxicity of nanoparticles.

Zoroddu MA, Medici S, Ledda A, Nurchi VM, Lachowicz JI, Peana M.

Curr Med Chem. 2014;21(33):3837-53. Review.

PMID:
25306903

Supplemental Content

Support Center